Your browser doesn't support javascript.
loading
Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
Mairpady Shambat, Srikanth; Gómez-Mejia, Alejandro; Schweizer, Tiziano A; Huemer, Markus; Chang, Chun-Chi; Acevedo, Claudio; Bergada-Pijuan, Judith; Vulin, Clément; Hofmaenner, Daniel A; Scheier, Thomas C; Hertegonne, Sanne; Parietti, Elena; Miroshnikova, Nataliya; Wendel Garcia, Pedro D; Hilty, Matthias P; Buehler, Philipp Karl; Schuepbach, Reto A; Brugger, Silvio D; Zinkernagel, Annelies S.
Afiliación
  • Mairpady Shambat S; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Gómez-Mejia A; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Schweizer TA; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Huemer M; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Chang CC; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Acevedo C; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Bergada-Pijuan J; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Vulin C; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Hofmaenner DA; Institute of Intensive Care, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Scheier TC; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Hertegonne S; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Parietti E; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Miroshnikova N; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Wendel Garcia PD; Institute of Intensive Care, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Hilty MP; Institute of Intensive Care, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Buehler PK; Institute of Intensive Care, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Schuepbach RA; Institute of Intensive Care, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Brugger SD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
  • Zinkernagel AS; Department of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
PLoS Pathog ; 18(1): e1010176, 2022 01.
Article en En | MEDLINE | ID: mdl-35007290

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Citocinas / Síndrome de Liberación de Citoquinas / COVID-19 / Neutrófilos Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monocitos / Citocinas / Síndrome de Liberación de Citoquinas / COVID-19 / Neutrófilos Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos